Home/Filings/3/0001209191-18-005261
3//SEC Filing

Merck Sharp & Dohme Corp. 3

Accession 0001209191-18-005261

CIK 0001566044other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 7:18 PM ET

Size

6.1 KB

Accession

0001209191-18-005261

Insider Transaction Report

Form 3
Period: 2018-01-24
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,243,168
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,243,168
Footnotes (1)
  • [F1]These securities are owned directly by Merck Sharp & Dohme Corp., which is a direct, wholly owned subsidiary of Merck & Co., Inc. ("Merck"). Merck is an indirect beneficial owner of the reported securities.

Issuer

Menlo Therapeutics, Inc.

CIK 0001566044

Entity typeother
IncorporatedNJ

Related Parties

1
  • filerCIK 0000942443

Filing Metadata

Form type
3
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 7:18 PM ET
Size
6.1 KB